New York A01017 amends the public health law to authorize education and outreach on drug-induced movement disorders by the Department of Health.
New York A01017 amends the public health law to authorize the Department of Health to develop and disseminate information on drug-induced movement disorders. This includes educational materials for healthcare providers on treatment and screening, developed in consultation with the Office of Mental Health. The program also aims to reduce stigma for people living with these disorders. The act takes effect concurrently with the 2024 amendment establishing a drug-induced movement disorder screening education program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.